Therapeutic Potential of Oncolytic Measles Virus: Promises and Challenges

被引:49
作者
Galanis, E. [1 ,2 ]
机构
[1] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Mol Med, Rochester, MN USA
关键词
SODIUM-IODIDE SYMPORTER; OVARIAN-CANCER; CARCINOEMBRYONIC ANTIGEN; GLIOBLASTOMA-MULTIFORME; CELLULAR RECEPTOR; PROSTATE-CANCER; VACCINE STRAIN; VIROTHERAPY; GLIOMAS; TUMOR;
D O I
10.1038/clpt.2010.211
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Measles virus (MV) is a negative-strand RNA virus (paramyxovirus) with oncolytic properties. The significant preclinical activity of MV vaccine strains against a variety of tumor models, their potent bystander effect, their selectivity against tumor cells, and their ability to retain their oncolytic properties when engineered and retargeted makes them a promising oncolytic platform. In this article, we review potential applications and challenges associated with use of MV strains as cancer therapeutics.
引用
收藏
页码:620 / 625
页数:6
相关论文
共 52 条
[51]  
2008, NCT00450814 VACCINE
[52]  
2008, NCT00390299 VIRAL TH